Drug Product
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Company Overview
About
Adragos Pharma is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Neurology
Quick Facts
HQ:Germany
Founded:1995
Employees:3,050
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
North America
Europe
Manufacturing Facilities
1 site worldwide
Baccinex SA
Rue de la Source 3, Courroux, 2822
Site Capabilities
1 capabilityMANUFACTURE
Regulatory Approvals
Drug Approval QH1LSC
FDA · #APR-I98MQNSV · 2019-07-01
Drug Approval H3FUAW
Health Canada · #APR-AQXOYGM9 · 2022-08-01
Certifications
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-23W7UMDF
Issued: 2020-04-28
Expires: 2025-05-06
Health Canada GMP
Health Canada
Cert #: CERT-5OCYFWAW
Issued: 2020-01-02
Expires: 2025-12-15
WHO GMP
World Health Organization
Cert #: CERT-Q85K4KNK
Issued: 2020-02-22
Expires: 2025-09-12
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-QAWSVCTL
Issued: 2020-04-07
Expires: 2025-12-19
Loading CDMO intelligence...
Key facts about Adragos Pharma
- Adragos Pharma is headquartered in Germany.
- Adragos Pharma was founded in 1995.
- Adragos Pharma has 3,050 employees.
- Adragos Pharma has one manufacturing site listed on CDMO Hub, in Courroux, Switzerland.
- Adragos Pharma's capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like Adragos Pharma
Directory pages this company appears in, each with the full list of matching manufacturers.